Health Canada Approves Novo’s Ozempic To Reduce Risk Of Kidney Function Decline, Cardiovascular Death
The approval from Health Canada for the indications is based on the results of a trial in which Semaglutide 1...
The approval from Health Canada for the indications is based on the results of a trial in which Semaglutide 1...
As summer heats up and tourists flock to the California coast, beachgoers should be on the lookout for sea lions...
News The TGA has approved semaglutide for reducing the risk of kidney function decline for adults with type...
Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes. Between...
New findings show that exposure to arsenic in drinking water may impact the formation of nephrons during embryonic growth and...
ROCKVILLE, Md., Aug. 12, 2025 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced new resources to empower people...